Cargando…
Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to develop statements to support clinical decision making, in terms of possible effe...
Autores principales: | Sacco, Simona, Merki-Feld, Gabriele S., Ægidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Gantenbein, Andreas R., Kurth, Tobias, Lampl, Christian, Lidegaard, Øjvind, Anne MacGregor, E., MaassenVanDenBrink, Antoinette, Mitsikostas, Dimos-Dimitrios, Nappi, Rossella Elena, Ntaios, George, Paemeleire, Koen, Sandset, Per Morten, Terwindt, Gisela Marie, Vetvik, Kjersti Grøtta, Martelletti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119173/ https://www.ncbi.nlm.nih.gov/pubmed/30171365 http://dx.doi.org/10.1186/s10194-018-0896-5 |
Ejemplares similares
-
Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2017) -
Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2018) -
Proposal for a European Hadron Facility (EHF)
por: Bradamante, Franco, et al.
Publicado: (1987) -
European Hadron Facility (EHF): letter of intent
por: Johannes Gutenberg-Universitaet. Mainz. Institut fuer Physik
Publicado: (1986) -
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
por: Lidegaard, Øjvind, et al.
Publicado: (2011)